The Applicability of Comorbidity Indices in Predicting Chemo toxicity in Non-Small Cell Lung Cancer

被引：1
作者：
Edahyr, Boshra [1 ]
Lind, Michael [2 ]
Karsera, Louise [1 ]
Mafi, Reza [1 ]
Wallace, Karen [1 ]
Howell, Gareth [1 ]
Hemmingway, Carl [1 ]
Stubbs, Karen [1 ]
机构：
[1] Univ Hull, Acad Oncol, Cottingham, England
[2] Univ Hull, Hull York Med Sch, Cottingham, England
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
Co-morbidity; toxicity; predictive;
D O I：
10.1016/j.jtho.2016.11.2038
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PUB068
引用
收藏
页码：S1487 / S1488
页数：2
相关论文
共 50 条
  • [21] The influence of comorbidity and other risk factors on early postoperative complications after lobectomy for non-small cell lung cancer
    Kowalewski, Janusz
    Sedlak, Anna
    KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA, 2009, 6 (04): : 359 - 363
  • [22] Comorbidity as a Prognostic Factor in Elderly Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
    Sazdanic-Velikic, Danica
    Tepavac, Aleksandar
    Lalic, Nensi
    Stojkovic, Ivana
    Secen, Nevena
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S914 - S914
  • [23] Toxicity of definitive and post-operative radiation following ipilimumab in non-small cell lung cancer
    Boyer, Matthew J.
    Gu, Lin
    Wang, Xiaofei
    Kelsey, Chris R.
    Yoo, David S.
    Onaitis, Mark W.
    Dunphy, Frank R.
    Crawford, Jeffrey
    Ready, Neal E.
    Salama, Joseph K.
    LUNG CANCER, 2016, 98 : 76 - 78
  • [24] Association of Crizotinib Toxicity with Pharmacokinetics and Pharmacogenomics in Non-Small Cell Lung Cancer Harboring ALK Fusion Gene
    Tambo, Yuichi
    Yamada, Kazuhiko
    Umemura, Shigeki
    Saeki, Sho
    Nakamura, Yukiko
    Shukuya, Takehito
    Urata, Yoshiko
    Okuma, Yusuke
    Fukui, Tomoya
    Kogure, Yoshihito
    Daga, Haruko
    Hasegawa, Yoshinori
    Tsubata, Yukari
    Yoshida, Tatsuya
    Oizumi, Satoshi
    Tamura, Yosuke
    Mizugaki, Hidenori
    Fujiwara, Yutaka
    Hamada, Akinobu
    Ohe, Yuichiro
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S378 - S378
  • [25] Early High-Grade Thoracic Toxicity After Palliative Radiotherapy for Non-Small Cell Lung Cancer
    Nieder, Carsten
    Imingen, Kristian
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (01)
  • [26] Comparison of toxicity and outcome in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-) radiotherapy using IMRT or VMAT
    Wijsman, Robin
    Dankers, Frank
    Troost, Esther G. C.
    Hoffmann, Aswin L.
    van der Heijden, Erik H. F. M.
    de Geus-Oei, Lioe-Fee
    Bussink, Johan
    RADIOTHERAPY AND ONCOLOGY, 2017, 122 (02) : 295 - 299
  • [27] Charlson Comorbidity Index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation
    Simon, Tracey G.
    Beland, Michael D.
    Machan, Jason T.
    DiPetrillo, Thomas
    Dupuy, Damian E.
    EUROPEAN JOURNAL OF RADIOLOGY, 2012, 81 (12) : 4167 - 4172
  • [28] Re-Irradiation of Recurrent Non-Small Cell Lung Cancer
    Hunter, Benjamin
    Crockett, Cathryn
    Faivre-Finn, Corrinne
    Hiley, Crispin
    Salem, Ahmed
    SEMINARS IN RADIATION ONCOLOGY, 2021, 31 (02) : 124 - 132
  • [29] Stage III Non-small Cell Lung Cancer Management in England
    Adizie, J. B.
    Khakwani, A.
    Beckett, P.
    Navani, N.
    West, D.
    Woolhouse, I
    Harden, S., V
    CLINICAL ONCOLOGY, 2019, 31 (10) : 688 - 696
  • [30] Chemotherapy in elderly patients with advanced non-small cell lung cancer
    Quoix, Elisabeth
    Westeel, Virginie
    Zalcman, Gerard
    Milleron, Bernard
    LUNG CANCER, 2011, 74 (03) : 364 - 368
12345